Showing of 0 - 10 from 90 results
Dr reddy's - Total results - 90
Jul 24, 2017
India Inc salary mismatch: Private CEOs get up to 1,200 times more than staff, PSU chiefs just 3-4 timesTCS saw the ratio between top-paid executive pay and the median employee remuneration rise to 515 times (from 460 times in previous year), while the same for Lupin stood at 1,263 times (though down from 1,317 times) for Chairman.
Mar 09, 2017
Dr Reddy's shares hit near three-year low, drops 4% as Duvvada unit receives 13 observations from US FDAThe Duvvuda unit makes cytotoxic and hormonal injectables. It is an important unit for Dr Reddy’s
Nov 07, 2016
Hillary win may pose pricing challenges for pharma cos: ReportA Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing regulations for both brand name and generic drugs, according to a report.
Oct 10, 2016
Dr Reddy's launches generic Lamotrigine tablets in USThe company's product is generic version of GSK Group of companies' Lamictal tablets
Sep 16, 2016
Dr Reddy's inks pact with US-based Amgen to market three drugs in IndiaUnder the terms of collaboration, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India
Jul 07, 2016
Lupin, Dr Reddy's recall 1.7 lakh blood pressure, acidity tablets in USLupin Pharmaceuticals Inc -- is recalling 59,520 bottles of Lisinopril & Hydrochlorothiazid tablets USP 20mg/12.5mg, 5,880 bottles of Lisinopril tablets
Jun 17, 2016
According to a study, IITs and TIFR top in collaboration with industry and GovtThe Indian Institutes of Technology (IITs) and the Tata Institute of Fundamental Research (TIFR) have emerged as leaders in university-industry-government (UIG) collaborations in the last decade, according to new analysis of India's research and innovation landscape.
May 29, 2016
Sun Pharma gets US subpoena over generic drugs pricingThe U.S. Department of Justice (DoJ) has subpoenaed India's largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday. The DoJ's antitrust division has also asked Sun Pharma's U.S
Feb 01, 2016
Now, IPCA Labs gets warning letter from USFDA for manufacturing lapses at 3 plantsThe plants have already been banned from supplying to the United States after the FDA inspected them in July 2014, January 2015 and March 2015
Dec 31, 2015
Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility